China Health Technology Group Holding Co (HKSE:01069) Days Sales Outstanding : 53.47 (As of Dec. 2023)

View and export this data going back to 2009. Start your Free Trial

What is China Health Technology Group Holding Co Days Sales Outstanding?

China Health Technology Group Holding Co's average Accounts Receivable for the six months ended in Dec. 2023 was HK$6.10 Mil. China Health Technology Group Holding Co's Revenue for the six months ended in Dec. 2023 was HK$20.80 Mil. Hence, China Health Technology Group Holding Co's Days Sales Outstanding for the six months ended in Dec. 2023 was 53.47.

The historical rank and industry rank for China Health Technology Group Holding Co's Days Sales Outstanding or its related term are showing as below:

HKSE:01069' s Days Sales Outstanding Range Over the Past 10 Years
Min: 32.23 Med: 258.76 Max: 454.89
Current: 32.23

During the past 13 years, China Health Technology Group Holding Co's highest Days Sales Outstanding was 454.89. The lowest was 32.23. And the median was 258.76.

HKSE:01069's Days Sales Outstanding is ranked better than
81.47% of 286 companies
in the Forest Products industry
Industry Median: 53.98 vs HKSE:01069: 32.23

China Health Technology Group Holding Co's Days Sales Outstanding increased from Dec. 2022 (28.62) to Dec. 2023 (53.47).

China Health Technology Group Holding Co Days Sales Outstanding Historical Data

The historical data trend for China Health Technology Group Holding Co's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Health Technology Group Holding Co Days Sales Outstanding Chart

China Health Technology Group Holding Co Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Jun22

Jun23

Days Sales Outstanding

Get a 7-Day Free Trial

241.88

145.20

355.85

275.63

34.04

China Health Technology Group Holding Co Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Dec21	Jun22	Dec22	Jun23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial															166.84	-	28.62	26.29	53.47

Competitive Comparison of China Health Technology Group Holding Co's Days Sales Outstanding

For the Lumber & Wood Production subindustry, China Health Technology Group Holding Co's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

China Health Technology Group Holding Co's Days Sales Outstanding Distribution in the Forest Products Industry

For the Forest Products industry and Basic Materials sector, China Health Technology Group Holding Co's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where China Health Technology Group Holding Co's Days Sales Outstanding falls into.

China Health Technology Group Holding Co Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

China Health Technology Group Holding Co's Days Sales Outstanding for the fiscal year that ended in Jun. 2023 is calculated as

	Days Sales Outstanding (A: Jun. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2022 )	+	Accounts Receivable (A: Jun. 2023 ))	/	count )	/	Revenue (A: Jun. 2023 )	*	Days in Period
=	( (4.397	+	7.583)	/	2 )	/	64.224	*	365
=	5.99					/	64.224	*	365
=	34.04

China Health Technology Group Holding Co's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (7.583	+	4.607)	/	2 )	/	20.804	*	365 / 2
=	6.095					/	20.804	*	365 / 2
=	53.47

China Health Technology Group Holding Co (HKSE:01069) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

China Health Technology Group Holding Co Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of China Health Technology Group Holding Co's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

China Health Technology Group Holding Co (HKSE:01069) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Forest Products » China Health Technology Group Holding Co Ltd (HKSE:01069) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

CHBOF:USA

Address

Binhe Road South, Room 4101, Phase II Jingji Binhe Shidai Tower North, Futian District, Shenzhen, CHN

Website

http://www.caflc.co

China Health Technology Group Holding Co Ltd Formerly China Bozza Development Holdings Ltd is an investment holding company. It is engaged in the business of management of new agriculture and forestry resources in the People's Republic of China. The company has two reportable segments including the Forestry business and Ginseng Business. The forestry management business includes plantation, logging, and sale of timber-related products and the Ginseng Business includes ginseng plantation and trading of related products. The company generates a majority of its revenue from the Ginseng business segment. Geographically company generates its key revenue from the PRC.

Executives

Huang Hou	2201 Interest of corporation controlled by you
Huang Hou	2101 Beneficial owner
Able Planet International Limited
China Bozza Scheme Limited
Arab Osman Mohammed
Lai Wing Lun
Wang Yue	2101 Beneficial owner
Long Yijia	2202 Interest of your spouse

China Health Technology Group Holding Co (HKSE:01069) Headlines

No Headlines